< Back

rAAVen to Present at #ASGCT2024 and Myrtelle Symposium

Daniel Williams

21 Μαρ 2023

This is placeholder text. To change this content, double-click on the element and click Change Content.

rAAVen Therapeutics is pleased to share the news on our participation in this year’s #ASGCT2024, and the symposium held by Myrtelle, Inc., where we will be presenting the latest findings on AAVs targeting oligodendrocytes.